The Scientist

» embryonic stem cells and disease/medicine

Most Recent

image: Setback for Malaria Vaccine

Setback for Malaria Vaccine

By | November 9, 2012

The malaria vaccine under development by GSK and the PATH initiative only protects about one in three babies, though some researchers say those odds are better than nothing.

0 Comments

image: Epigenetics Armed German E. coli

Epigenetics Armed German E. coli

By | November 9, 2012

The 2011 outbreak in Germany that caused some 50 deaths was caused by a strain of E. coli with a complex mechanism of gene regulation.

3 Comments

image: How Mole Rats Fight Cancer

How Mole Rats Fight Cancer

By | November 6, 2012

Blind mole rats resist cancer by killing cells that proliferate in a similar way to tumor cells.

0 Comments

image: The Brain on Anesthetics

The Brain on Anesthetics

By | November 5, 2012

Recording brain activity as patients are anesthetized for surgery, researchers identify a pattern that may signal loss of consciousness.  

1 Comment

image: Gingers More Prone to Skin Cancer

Gingers More Prone to Skin Cancer

By | November 2, 2012

Researchers identify an unexpected molecular explanation for the higher incidence of skin cancer in redheads.

5 Comments

image: Contributors

Contributors

By | November 1, 2012

Meet some of the people featured in the November 2012 issue of The Scientist.

0 Comments

image: Omega-3s: Fishing for a Mechanism

Omega-3s: Fishing for a Mechanism

By | November 1, 2012

Despite abundant evidence supporting their ability to help prevent and treat cardiovascular disease, the therapeutic effectiveness of fish oil–derived fatty acids remains controversial.

4 Comments

image: The Road Less Traveled

The Road Less Traveled

By | November 1, 2012

First, Aravinda Chakravarti drew a map of how scientists might unravel the genetics of complex disease. Then he blazed the trail.

0 Comments

image: Tumor Snipers

Tumor Snipers

By | November 1, 2012

After two headline successes, companies rush to develop “smart bomb” cancer drugs.

0 Comments

image: Long and Rocky Roads

Long and Rocky Roads

By | November 1, 2012

From basic research to beneficial therapies

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech